46 results
424B5
VINC
Vincerx Pharma Inc
29 Apr 24
Prospectus supplement for primary offering
5:14pm
, which may be offset by certain U.S.-source capital losses of the non-U.S. holder, if any, provided that the non-U.S. holder has timely filed U.S
424B5
VINC
Vincerx Pharma Inc
25 Apr 24
Prospectus supplement for primary offering
4:10pm
and such holder’s country of residence) on the net gain derived from the disposition, which may be offset by certain U.S.-source capital losses of the non-U.S
8-K
EX-99.1
hh9wq
14 Nov 23
Vincerx Pharma Reports Third Quarter 2023 Financial Results
12:00am
8-K
EX-99.1
h2rxp55 ovt
11 May 23
Vincerx Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.1
lkful
10 Nov 22
Vincerx Pharma Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
4:27pm
424B3
e7b7x3ewk2 qzcb
11 Jan 22
Prospectus supplement
4:04pm
424B3
jx2844n9hq44z4lgh 0e
11 Jan 22
Prospectus supplement
4:04pm
POS AM
5gkx8x
7 Jan 22
Prospectus update (post-effective amendment)
12:00am
POS AM
z43cowzv
7 Jan 22
Prospectus update (post-effective amendment)
12:00am
424B3
vbaq pljkubpieu
12 Nov 21
Prospectus supplement
6:25am